fda ruling semaglutide Approves Oral Semaglutide: First GLP-1 Pill for Weight Loss FDA moves to remove GLP-1

There is no reconstitution, no needles, and no meal-timing requirement in how it has been characterized

After declaring the semaglutide shortage resolved in February 2025, the agency began restricting outsourcing facilities from compounding the drug

[Abstract] Cell apoptosis rate was detected by flow cytometry using Annexin-V/PI staining

PMID: 40873114 Drug Des Devel Ther Semaglutide Inhibits Osteoblast Ferroptosis Induced by Diabetic Periodontitis via Modulating the Wnt5a/Ror2/p38 MAPK Signaling Pathway

Improved blood circulation means more oxygen and nutrients reach the affected areas, accelerating the healing process